Form 4: KORU Medical Systems Executive Reports Stock Transactions
SEC Form 4 Filing
Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 17, 2025, Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, vested 5,893 shares of common stock from restricted stock units.
- He then disposed of 2,168 shares to cover tax obligations at a price of $2.887 per share.
- Following these transactions, Miller directly owns 3,725 shares of KORU Medical Systems common stock and 17,679 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 03/21/2025 | Date of signature on the Form 4 filing. |
Keywords
KORU Medical Systems, KRMD, Form 4, Beneficial Ownership, Executive Compensation, Restricted Stock Units, Kenneth E. Miller, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.